User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 8 results.
    • Journal article
    Anticoagulant therapy in acute lung injury.
    Laterre, Pierre-François[UCL] Wittebole, Xavier Dhainaut, Jean-François (2003) Critical care medicine — Vol. 31, no. 4 Suppl, p. S329-36 (2003)
    • Journal article
    International integrated database for the evaluation of severe sepsis (INDEPTH): clinical evaluation committee report on the safety of drotrecogin alfa (activated) therapy.
    Dhainaut, Jean-François INDEPTH Clinical Evaluation Committee Laterre, Pierre-François[UCL] (2008) Current medical research and opinion — Vol. 24, no.4, p. 1187-1197 (2008)
    • Journal article
    Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis
    Ely, E. Wesley Laterre, Pierre-François[UCL] Angus, Derek C. Helterbrand, Jeffrey D. Levy, Howard Dhainaut, Jean-François Vincent, Jean-Louis Macias, William L. Bernard, Gordon R. PROWESS Investigators (2003) Critical Care Medicine — Vol. 31, no. 1, p. 12-19 (2003)
    • Journal article
    Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis
    Macias, William L. Vallet, Benoit Bernard, Gordon R. Vincent, Jean-Louis Laterre, Pierre-François[UCL] Nelson, David R. Derchak, Alexander Dhainaut, Jean-François (2004) Critical Care Medicine — Vol. 32, no. 12, p. 2385-2391 (2004)
    • Journal article
    Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial
    Opal, Steven Laterre, Pierre-François[UCL] Abraham, Edward Francois, Bruno Wittebole, Xavier[UCL] Lowry, Stephen Dhainaut, Jean-François Warren, Brian Dugernier, Thierry Lopez, Angel Sanchez, Miguel Demeyer, Ignace Jauregui, Luis Lorente, Jose Angel McGee, William Reinhart, Konrad Kljucar, Sascha Souza, Sonia Pribble, John (2004) Critical Care Medicine — Vol. 32, no. 2, p. 332-341 (2004)
    • Journal article
    Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, Gordon R Vincent, Jean-Louis Laterre, Pierre-François[UCL] La Rosa, Steven P Dhainaut, Jean-François Lopez-Rodriguez, Angel Steingrub, Jay S Garber, GaryE Helterbrand, Jeffrey D Ely, E Wesley Fisher, Charles J Hantson, Philippe[UCL] Reynaert, Marc[UCL] Wittebole, Xavier[UCL] the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group (2001) New England Journal of Medicine — Vol. 344, no. 10, p. 699-709 (2001)
    • Journal article
    Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis.
    Laterre, Pierre-François[UCL] Macias, William Janes, Jonathan Williams, Mark D Nelson, David R Girbes, Amand R J Dhainaut, Jean-François Abraham, Edward (2008) Critical care (London, England) — Vol. 12, no. 5, p. R117 (2008)
    • Journal article
    Drotrecogin alfa (activated) in adults with septic shock.
    Ranieri, V Marco Thompson, B Taylor Barie, Philip S Dhainaut, Jean-François Douglas, Ivor S Finfer, Simon Gårdlund, Bengt Marshall, John C Rhodes, Andrew Artigas, Antonio Payen, Didier Tenhunen, Jyrki Al-Khalidi, Hussein R Thompson, Vivian Janes, Jonathan Macias, William L Vangerow, Burkhard Williams, Mark D PROWESS-SHOCK Study Group Dive, Alain-Michel[UCL] Laterre, Pierre-François[UCL] (2012) New England Journal of Medicine — Vol. 366, no.22, p. 2055-64 (2012)